Ductal Fas antigen and the pathobiology of Sjögren's syndrome
De Vita, S.
Clinical and Experimental Rheumatology 14(3): 231-234
1996
ISSN/ISBN: 0392-856X PMID: 8809435 Document Number: 462556
Document emailed within 1 workday
Related Documents
Matsumura, R.; Kagami, M.; Tomioka, H.; Tanabe, E.; Sugiyama, T.; Sueishi, M.; Nakajima, A.; Azuma, M.; Okumura, K. 1996: Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome Clinical and Experimental Rheumatology 14(3): 309-311Nahir, A.M.; Scharf, Y.; Gidoni, O.; Koren, L.; Zonis, S.; Barzilai, A. 1980: HL-A antigen in Sjögren's syndrome Annals of Ophthalmology 12(9): 1084-1086
Teppo, A.M. 1981: Enzyme immunoassay of antibodies to Sjögren's syndrome B antigen Clinical Chemistry 27(8): 1341-1345
Nelson, J.D.; Friedlaender, M.; Yeatts, R.P.; Yee, R.; McDermott, M.; Orlin, S.; Gallagher, S.C.; Shrotriya, R.C. 1998: Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. the MGi PHARMA Sjögren's Syndrome Study Group Advances in Experimental Medicine and Biology 438: 979-983
Whittingham, S.; Naselli, G.; Mcneilage, L.J.; Coppel, R.L.; Sturgess, A.D. 1987: Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen Lancet 2(8549): 1-3
Li, H.-b.; Zhang, F.-c.; Zhang, X.; Gan, X.-d.; Shi, Y.-p.; Bai, Y.-n.; Tang, F.-l. 2010: Expression of SSA antigen epitopes in minor salivary glands from patients with primary Sjögren's syndrome Zhonghua Yi Xue Za Zhi 90(17): 1187-1191
Kristt, D.; Feinmesser, M. 1996: Pathobiology of AIDS in the central nervous system--an epidemic with an elusive pathobiology Harefuah 131(7-8): 285-288
Gan, Y.J. 1991: Using immunofluorescence and immunoenzyme to detect EB virus associated antigen in labial gland biopsies from patients with Sjogren's syndrome Zhonghua Kou Qiang Yi Xue Za Zhi 26(3): 146-148
Tensing, E.K.; Solovieva, S.A.; Tervahartiala, T.; Nordström, D.C.; Laine, M.; Niissalo, S.; Konttinen, Y.T. 2001: Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin Clinical and Experimental Rheumatology 19(3): 313-316
Kirtava, Z.Z.; Guseva, N.G.; Simonova, M.V.; Lekakh, I.V.; Poverennyĭ, A.M. 1988: Clinical significance of anti-Ro and anti-la antigen antibodies in Sjögren's disease and syndrome Terapevticheskii Arkhiv 60(4): 21-25
Radenska-Lopovok, S.G. 1990: The morphological characteristics of the changes in the gastrointestinal tract in Sjögren's disease and Sjögren's syndrome Arkhiv Patologii 52(5): 40-46
Morozova, R.P.; Zhaboiedov, H.D.; Kirieiev, V.V.; Nikolenko, I.A. 1996: The normal tear fluid and decreased tearing in patients with Sjögren's disease and Sjögren's syndrome. II. the lipid content Ukrainskii Biokhimicheskii Zhurnal 68(2): 82-87
Brito-Zerón, P.; Acar-Denizli, N.; Ng, W.-F.; Zeher, M.; Rasmussen, A.; Mandl, T.; Seror, R.; Li, X.; Baldini, C.; Gottenberg, J.-E.; Danda, D.; Quartuccio, L.; Priori, R.; Hernandez-Molina, G.; Armagan, B.; Kruize, A.A.; Kwok, S.-K.; Kvarnström, M.; Praprotnik, S.; Sène, D.; Bartoloni, E.; Solans, R.; Rischmueller, M.; Suzuki, Y.; Isenberg, D.A.; Valim, V.; Wiland, P.; Nordmark, G.; Fraile, G.; Bootsma, H.; Nakamura, T.; Giacomelli, R.; Devauchelle-Pensec, V.; Knopf, A.; Bombardieri, M.; Trevisani, V.-F.; Hammenfors, D.; Pasoto, S.G.; Retamozo, S.; Gheita, T.A.; Atzeni, F.; Morel, J.; Vollenveider, C.; Horvath, I.-F.; Sivils, K.L.; Olsson, P.; De Vita, S.; Sánchez-Guerrero, J.; Kilic, L.; Wahren-Herlenius, M.; Mariette, X.; Ramos-Casal 2018: How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project) Clinical and Experimental Rheumatology 36 Suppl 112(3): 102-112
Papantoniou, V.; Tsiouris, S.; Koutsikos, J.; Ptohis, N.; Lazaris, D.; Zerva, C. 2006: Increased serum carbohydrate antigen 19-9 in relapsed ductal breast carcinoma Hellenic Journal of Nuclear Medicine 9(1): 36-38
Yamauchi, K. 1983: Immunologic abnormalities and classification of Sjögren's syndrome--Mikulicz syndrome and its relationship to sicca syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 41(1): 224-227
Niewiadomska, H.; Jeziorski, A.; Olborski, B. 1998: The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma Journal of Experimental and Clinical Cancer Research: Cr 17(4): 503-510
Frierson, H.F. 1993: Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 6(3): 290-294
Kinkor, Z.; Skálová, A. 2005: Acinic cell-like differentiation in invasive ductal carcinoma and in ductal hyperplasia of the breast--report of two cases Ceskoslovenska Patologie 41(1): 29-33
Oddis, C.V.; Eisenbeis, C.H.; Reidbord, H.E.; Steen, V.D.; Medsger, T.A. 1987: Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant Journal of Rheumatology 14(5): 942-948
Appelboom, T.; Vandermoeten, R.; Vandenabeele, G. 1975: Pathogenetic observations apropos of an association of Crest's syndrome and Gougerot-Sjögren's syndrome Revue du Rhumatisme et des Maladies Osteo-Articulaires 42(2): 127-130